Transcatheter Catheterl Embolization with N-butyl-2-cyanoacrylate

Transcatheter Catheterl Embolization with N-butyl-2-cyanoacrylate - NBCA of embolic meterial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022611

Enrollment

Registered

2016-08-01

Start date

2016-09-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patient with the situation that transcatheter embolization has to be performed using NBCA

Interventions

Target vessel is embolized using NBCA in transcatheter embolization.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The case in which The usage of NBCA is more effective than other embolic materials in transcatheter embolization. Target disease: Bleeding and vascular disease, for example, aneurysm.

Exclusion criteria

Exclusion criteria: The case in which the usage of other embolic materials is more effective than NBCA in transcatheter embolization.

Design outcomes

Primary

Measure	Time frame
Consideration for embolic effect using CT after about 1 week	—

Secondary

Measure	Time frame
Check whether there is any allergy or toxication Check whether there is complication of characteristic NBCA	—

Countries

Japan

Contacts

Public ContactAkihiro Furuta

Kyoto University Graduate School of Medicine Department of Diagnostic Imaging and Nuclear Medicine

akihirof@kuhp.kyoto-u.ac.jp075-751-3760

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026